[Federal Register Volume 77, Number 144 (Thursday, July 26, 2012)]
[Notices]
[Page 43863]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-18202]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Boehringer Ingelheim Chemicals Inc.

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 8, 2012, Boehringer 
Ingelheim Chemicals Inc., 2820 N. Normandy Drive, Petersburg, Virginia 
23805-9372, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Lisdexamfetamine (1205)....................  II
Methylphenidate (1724).....................  II
Methadone (9250)...........................  II
Methadone Intermediate (9254)..............  II
Tapentadol (9780)..........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for sale to its customers for formulation into finished 
pharmaceuticals. In reference to Methadone Intermediate (9254) the 
company plans to produce Methadone HCL active pharmaceutical 
ingredients (APIs) for sale to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than September 24, 2012.

    Dated: July 17, 2012.
 Joseph T. Rannazzisi,
 Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration
[FR Doc. 2012-18202 Filed 7-25-12; 8:45 am]
BILLING CODE 4410-09-P